depression on semaglutide and Depression: What Is the Relationship? GLP-1 drugs tied to lower

Safety considerations for weight loss peptide dosing Peptide safety depends partly on accurate dosing

The anesthesia team needs very specific timing, last doses, and side effects on therapy

Although both Wegovy and Mounjaro are glucagon-like peptide-1 (GLP-1) receptor agonists which help you lose weight by mimicking the effects of the naturally occurring hormone GLP-1, Mounjaro also mimics the effects of another digestive hormone: glucose-dependent insulinotropic polypeptide (GIP)

The novel dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist Tirzepatide transiently delays gastric emptying similarly to selective long-acting GLP-1 receptor agonists